ESTA Profile
Establishment Labs Holdings Inc. is a leading medical technology firm specializing in the design, manufacture, and marketing of advanced medical devices for aesthetic and reconstructive plastic surgery. The company is particularly renowned for its innovative silicone gel-filled breast implants, which are marketed under the Motiva Implants brand. These products are engineered to meet the highest standards of safety and performance in the field of cosmetic and reconstructive surgery.
The company's flagship product line includes the Motiva Ergonomix and Motiva Ergonomix2, which are gravity-sensitive round soft silicone-gel-filled breast implants designed to provide a natural look and feel. These implants are known for their advanced ergonomic design, enhancing both comfort and aesthetic outcomes for patients. Additionally, Establishment Labs offers the Motiva Flora Tissue Expander, used in breast reconstruction procedures to gradually expand the tissue before the final implant is placed.
Establishment Labs also distributes the Puregraft line of products, which facilitates the autologous adipose tissue harvesting and redistribution process. This technology is crucial for procedures requiring the transfer of a patient's own fat, such as in breast reconstruction and body contouring. The company's products are sold through a network of exclusive distributors and a direct sales force, catering to markets across Europe, Latin America, Asia-Pacific, and other international regions.
Founded in 2004 and headquartered in Alajuela, Costa Rica, Establishment Labs Holdings Inc. has established a strong reputation in the medical device industry. The company's commitment to innovation and quality is evident in its ongoing research and development efforts, aimed at advancing the field of plastic and reconstructive surgery. Its global presence and dedication to excellence make it a key player in the medical technology sector
|
